New IDEAS: Consent Best Practices: Essential Elements and Cultural Considerations
- Shared screen with speaker view

29:37
What about scrubs?

29:52
does that also create a situation of undue influence?

41:01
please share study slides and recording after the meeting. Thank you

41:54
Slides, recording, and resources will be shared after the presentation

51:18
Just a reminder to everyone that this is NOT a randomized study. Randomization should not be discussed.

52:34
I just want to say "thank you!" for the comment about using "participant" rather then "subject". I've had people comment that "subject" make them feel like a lab rat.

53:13
great. Thank you

54:45
Thanks Lucy! For additional questions or concerns about the protocol or operations, please email newideas@acr.org

55:34
Can you unmute me?

56:13
Good point! I would always say "if you become a participant" rather than saying for example, "subjects in the study will undergo.."

56:46
Never mind Stephanie covered it!

56:53
Excellent presentation. Thank you!

58:22
I can help with that question a bit

58:43
I have a patient visit due now. Thank you and take care everyone.

59:57
Thanks Lucy, great examples

59:58
Also for FDA audits the PHI needs to be disclosed

01:00:46
Agree with regulatory audits, standard language

01:02:55
Thank you for such an impactful, well-organized presentation!

01:03:03
Thanks for the great presentation, Casey, Marissa and Jasmine!

01:03:09
Thank you!